Company profile

AimerBio company profile

AimerBio is a pharmaceutical company that engages in the long-term modification of peptides and peptide-drug conjugation technology. At present, it has three technology platforms for peptide drug design, optimization and screening, long-acting peptide modification technology, peptide conjugated drugs, and 1 related invention patent. The company focuses on the field of peptide drugs, integrates today's international advanced peptide technology, establishes a peptide drug innovation technology platform, R&D pipeline, and product pipeline, and provides process technology development services and commercial production services for cooperative units. A first-class peptide pharmaceutical company.

Business identity

Operating status
Active
Company type
For Profit
Founded
2018-09-01

Headquarters

Headquarters
Anhui, China, Hefei
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.